ClinConnect ClinConnect Logo
Search / Trial NCT04989712

MOReS Freestyle Libre Validation Study

Launched by OXFORD BROOKES UNIVERSITY · Aug 3, 2021

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Mvpa Glucose Cognition Children Adolescents

ClinConnect Summary

The MOReS Freestyle Libre Validation Study is researching how taking breaks to stand and move around can affect young people's physical health and mental performance. The study aims to see if short periods of standing and moderate exercise can improve both physical fitness and cognitive abilities, such as thinking and problem-solving, in young individuals aged 9 to 18 years.

To participate in the study, young people should be generally healthy, without serious medical conditions that could affect their ability to join in the activities. However, those with epilepsy that isn't well controlled, diabetes, or certain other medical conditions, as well as those taking specific medications, cannot take part. If eligible, participants can expect to take part in fun activities that involve standing and moving, and they will help researchers understand the benefits of breaking up long periods of sitting. This study is currently looking for volunteers, so if you know a young person who fits the criteria and is interested in improving their health, this could be a great opportunity!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Young people aged 9-18 years old
  • No significant current or previous medical history
  • Are able to participate safely in the study's assessments and brief interrupted sitting moderate to vigorous physical activity (MVPA)
  • Exclusion Criteria:
  • Those with uncontrolled epilepsy/seizures (stable epilepsy/on medication \> 12 weeks)
  • Those who have Type 1 and Type 2 diabetes or other glucose intolerance or on medication for such conditions
  • Those who experience contraindications to physical training
  • Those who are on any form of steroids, anti-anxiety/depression drugs, birth control, beta-blockers, statin, adrenaline, HIV or Hepatitis C medications (these medications can affect the readings during the oral glucose tolerance test)
  • Those with known allergies to plasters

About Oxford Brookes University

Oxford Brookes University is a leading UK institution known for its commitment to innovative research and academic excellence. With a strong emphasis on interdisciplinary collaboration, the university actively engages in various clinical trials aimed at advancing healthcare and improving patient outcomes. Leveraging its research expertise and state-of-the-art facilities, Oxford Brookes University fosters a dynamic environment for the development of novel therapies and interventions, contributing to the broader scientific community while prioritizing ethical standards and participant safety.

Locations

Oxford, Oxfordshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

Helen Dawes, PhD

Principal Investigator

Oxford Brookes University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials